Condition

Diabetes, Type I

ClinicalTrials.gov condition label

Clinical trials10

Recruiting0

Common interventions14

Lead sponsors shown10

Clinical trials

10 shown

A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 DiabetesNCT06938334 · 2025-08-15

NOT_YET_RECRUITING

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CADNCT01754259 · 2013-04-01

Diabetes Virus Detection Project, Intervention With GAD-alumNCT01129232 · 2011-01-01

A Randomised, Single Centre, Double-Blind, Two-Period Crossover, Glucose Clamp TrialNCT00810589 · 2008-11-01

Childhood DiabetesNCT00804232 · 2008-01-01

Closing the Loop Between Glucose Sensor and Insulin Pump-developing an AlgorithmNCT00541515 · 2007-10-01

Efficacy & Safety of Inhaled Insulin in Type 1 DiabetesNCT00308308 · 2006-02-01

12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.NCT00046150 · 2002-05-01

Diabetes Type 1, Treatment Study Atacand/Placebo After Kidney BiopsyNCT00328302 · 2000-09-01

Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree RelativesNCT00654121 · 2000-02-01

Common interventions

PlaceboDRUG2 Active comparatorDRUG1 Actrapid HMDRUG1 Autologous CD34+ cell enriched population containing HSPCs transduced ex vivo using a LVV encoding the hPD-L1 DNAGENETIC1 CandesartanDRUG1 childhood diabetesBEHAVIORAL1 continuous glucose sensors and insulin pumpDEVICE1 GAD-alumDRUG1 Humalog NPL InsulinDRUG1 Insulin glulisine (HMR1964)DRUG1 LevemirDRUG1 PlaceboOTHER1 RanolazineDRUG1 Technosphere InsulinDRUG1

Leading sponsors

Altheia Science1 Brigham and Women's Hospital1 Karolinska University Hospital1 Mannkind Corporation1 Medical University of Graz1 Oslo University Hospital1 Rabin Medical Center1 Sanofi1 Universitair Ziekenhuis Brussel1 Vardalinstitutet The Swedish Institute for Health Sciences1

Trial status mix

COMPLETED6

UNKNOWN2

NOT_YET_RECRUITING1

TERMINATED1

Phase mix

PHASE23

PHASE33

NA2

PHASE12

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.